History
  • No items yet
midpage
Biomed Pharmaceuticals, Inc. v. Oxford Health Plans (N.Y.), Inc.
775 F. Supp. 2d 730
S.D.N.Y.
2011
Read the full case

Background

  • This is a diversity-removal ERISA action in SDNY by Biomed against Oxford regarding plan benefits and alleged misconduct.
  • Biomed filed a Second Amended Complaint asserting ERISA §§ 502(a)(1)(B) and 502(a)(3) claims plus a state-law defamation claim.
  • Biomed alleges Oxford reduced in-network payments to Biomed for out-of-network care and improperly denied benefits.
  • Biomed had assigned rights from the Patient, but the assignment language limits suit to monetary recovery for services rendered.
  • Oxford moved to dismiss Counts 2–5; the court granted in part, dismissing those counts for lack of standing and as duplicative or improper equitable relief, and asserting time-bar for the defamation claim.
  • Count One remained intact as the sole ERISA § 502(a)(1)(B) claim and the only surviving action.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether the assignment authorizes declaratory/injunctive relief Biomed argues the assignment covers all Patient rights under the Plan. Oxford contends the assignment only permits money damages for Biomed's services. Counts 2–4 dismissed for lack of proper relief under the assignment.
Whether § 502(a)(3) claims are appropriate where § 502(a)(1)(B) suffices Biomed seeks equitable relief for alleged procedural deficiencies. Equitable relief is not appropriate where monetary relief is available. Counts 2–4 dismissed as duplicative and not warranting § 502(a)(3) relief.
Whether § 502(a)(3) claims can survive if not duplicative If not duplicative, § 502(a)(3) could provide relief. Varity allows § 502(a)(3) only where § 502(a)(1)(B) provides no adequate relief. Counts 2–4 fail to demonstrate irreducible need for equitable relief; they are dismissed.
Whether the defamation claim is time-barred Biomed alleges statements after 2009, within a year before filing. Time-bar applies; vagueness cannot rescue a time-barred claim. Count Five time-barred and dismissed.
Whether the defamation claim has adequate specificity Biomed identified several statements by Oxford. Biomed fails to specify who said what to whom and when, other than one date. Count Five dismissed for lack of specificity and notice.

Key Cases Cited

  • Varity Corp. v. Howe, 516 U.S. 489 (U.S. 1996) (equitable relief under § 502(a)(3) not normally appropriate where § 502(a)(1)(B) relief exists)
  • Frommert v. Conkright, 433 F.3d 254 (2d Cir. 2006) (breach of fiduciary duty claims may be viable where § 502(a)(1)(B) relief is inadequate)
  • Devlin v. Empire Blue Cross & Blue Shield, 274 F.3d 76 (2d Cir. 2001) ( affirms interplay between § 502(a)(1)(B) and § 502(a)(3) relief)
  • Kendall v. Employees Retirement Plan of Avon Products, 561 F.3d 112 (2d Cir. 2009) (§ 1132(a)(3) applies to injunctive relief; many claims seek monetary damages)
  • Pelosi v. Schwab Capital Markets, L.P., 462 F. Supp. 2d 503 (S.D.N.Y. 2006) (notes limits on equitable relief under ERISA)
  • CIGNA Corp. v. Amara, 131 S. Ct. 1866 (U.S. 2011) (interprets 'appropriate equitable relief' under § 502(a)(3))
  • Frommert v. Conkright, 433 F.3d 254 (2d Cir. 2006) (discusses relief available under § 502(a)(1)(B) vs § 502(a)(3))
  • Reilly v. Natwest Markets Group Inc., 181 F.3d 253 (2d Cir. 1999) (pleading standard for defamation notices)
  • Dillon v. City of New York, 261 A.D.2d 34, 704 N.Y.S.2d 1 (N.Y. App. Div. 1999) (defamation pleading standards in New York)
  • Gmurzynska v. Hutton, 355 F.3d 206 (2d Cir. 2004) (pleading and notice requirements in defamation cases)
Read the full case

Case Details

Case Name: Biomed Pharmaceuticals, Inc. v. Oxford Health Plans (N.Y.), Inc.
Court Name: District Court, S.D. New York
Date Published: Jul 5, 2011
Citation: 775 F. Supp. 2d 730
Docket Number: 10 Civ. 7427(JSR)
Court Abbreviation: S.D.N.Y.